Radiographic contrast media

BJU International, Supplement

Volumn 86, Issue 1, 2000, Pages 1-10

  Thomsen, H S ^a   Morcos, S K ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CIMETIDINE; CONTRAST MEDIUM; DIPHENHYDRAMINE; OXYGEN; PROCHLORPERAZINE; RANITIDINE;

ANAPHYLAXIS; BRONCHOSPASM; HEADACHE; HEART ARREST; HUMAN; HYPOTENSION; LARYNX EDEMA; NAUSEA; NEPHROTOXICITY; OSMOLALITY; PAIN; PRIORITY JOURNAL; REVIEW; URTICARIA; VISCOSITY; VOMITING;

EID: 0033936589     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.2000.00586.x     Document Type: Review

References (41)

1. Pollack HM, History of iodinated contrast media. In: Thomson HS, Muller RN, Mattrey RF, eds. Trends in Contrast Media. Berlin: Springer Verlag, 1999: 1-19
2. Thomson HS, Dorph S. High-osmolar and low-osmolar contrast media. An update on frequency of adverse drug reactions. Acta Radiol 1993; 34: 205-9
3. Grainger RG. Intravascular contrast media. In: Grainger RG, Allison D, eds. Grainger and Allison's Diagnostic Radiology: A Textbook of Medical Imaging. New York: Churchill Livingstone, 1997: 40-1
4. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990; 175: 621-8
5. Thomson HS, Bush WH Jr. Adverse effects of contrast media. Incidence, prevention and management. Drug Safety 1998; 19: 313-24
6. Lasser EC, Berry CC, Talner LB et al. Pretreatment with corticosteroids to alleviate reactions to intravascular contrast media. N Engl J Med 1987; 317: 845-9
7. Wolf GL, Mishkin MM, Roux SG et al. Comparison of the rates of adverse drug reactions. Ionic agents, ionic agents combined with steroids and non-ionic agents. Invest Radiol 1991; 26: 404-10
8. Lasser EC, Berry CC, Mishkin MM, Williamson B, Zheutlin N, Silverman JM. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. Am J Roentgenol 1994; 162: 523-6
9. Mukherjee JJ, Peppercorn PD, Reznek RH et al. Pheochromocytoma: Effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 1997; 202: 227-31
10. Yoshikawa H. Late adverse reactions to non-ionic contrast media. Radiology 1992; 183: 737-40
11. Morcos SK, Thomson HS, Webb JAW, and members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602-13
12. Porter GA. Radiocontrast-induced nephropathy. Nephrol Dial Transpl 1994; 9: 146-56
13. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast media associated nephrotoxicity and atheroembolism - a clinical review. Am J Kidney Dis 1994; 24: 713-7
14. Solomon R. Contrast medium-induced acute renal failure. Kidney Int 1998; 53: 230-42
15. Thomson HS, Golman K, Hemmingsen L. Larsen S, Skaarup P, Svendsen O. Contrast medium induced nephropathy: animal experiments. Frontiers Eur Radiol 1993; 9: 83-108
16. Berg KJ, Jakobsen JA. Nephrotoxicity related to X-ray contrast media. Adv X-Ray Contrast 1993; 1: 10-8
17. Katzberg WR. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297-312
18. Yamazaki H, Oi H, Matsushita M et al. Lack of correlation between gallbladder opacification in delayed CT and contrast-associated nephropathy. Eur Radiol 1997; 7: 1328-31
19. Almén T, Frennby B. Sterner G. Determination of glomerular filtration rate (GFR) with contrast media. In: Thomsen HS, Muller RN, Mattrey RF, eds. Trends in Contrast Media. Berlin: Springer Verlag, 1999; 81-94
20. Thomsen HS, Hvid-Jacobsen K. Estimation of glomerular filtration rate from a low dose injection of iohexol and a single blood sample. Invest Radiol 1991; 26: 332-6
21. Thomsen HS, Vestergaard A, Nielsen SL, Fogh-Andersen N, Golman K, Dorph S. Renal clearance of an ionic high-osmolar and a non-ionic low-osmolar contrast medium. Invest Radiol 1991; 26: 564-8
22. Frennby B. Use of iohexol clearance to determine the glomerular filtration rate. A comparison between different clearance techniques in man and animal. Doctoral Thesis, University of Lund, 1996
23. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-40
24. Morcos SK. Contrast media-induced nephrotoxicity -questions and answers. Br J Radiol 1998; 71: 357-65
25. Blomley MJK, Dawson P. The quantification of renal function with enhanced computed tomography. Br J Radiol 1996; 69: 989-95
26. Morcos SK, Epstein FH, Haylor J, Dobrota M. Aspects of contrast media nephrotoxicity. Eur J Radiol 1996; 23: 178-84
27. Morcos SK, El Nahas AM, Brown P, Haylor J. Effect of iodinated water soluble contrast media on urinary protein assays. Br Med J 1992; 305: 29
28. Love L, Johnson MS, Bresler ME et al. The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol 1994; 67: 951-7
29. Jakobsen JA, Lundby B, Kristoffersen DT, Borch KW, Hald JK, Berg KJ. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 1992; 182: 419-24
30. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-20
31. Rudnik MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254-61
32. Moore RD, Steinberg EP, Powe NR et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992; 182: 649-55
33. Barrett JB, Parfrey PS, Vavasour HM et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274-9
34. Katholi RE, Taylor GJ, Woods WT et al. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double blind randomized comparisons in human beings. Radiology 1993; 186: 183-7
35. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-8
36. Deray G, Jacobs C. Renal tolerance of nonionic dimers. Invest Radiol 1996; 31: 372-7
37. Morcos SK, Nahas AM. Advances in the understanding of the nephrotoxicity of radiocontrast media. Nephron 1998; 78: 249-52
38. Duarte CG, Zhang J, Ellis S. The SHR as a small animal model for radiocontrast renal failure. Relation of nephrotoxicity to animal's age, gender, strain, and dose of radiocontrast. Renal Failure 1997; 19: 723-43
39. Thomsen HS. Contrast nephropathy. In: Thomsen HS, Muller RN, Mattrey RF, eds. Trends in Contrast Media. Berlin: Springer Verlag, 1999; 103-16
40. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-20
41. Thomsen HS, Morcos SK, and the ESUR Contrast Media Safety Committee. Contrast media and metformin. Guidelines to diminish the risk of lactic acidosis in non-insulin dependent diabetics after administration of contrast media. Eur Radiol 1999; 9: 738-40